PRENATAL AND LACTATION SUPPLEMENTS TO ENHANCE CENTRAL NERVOUS SYSTEM DEVELOPMENT OF OFFSPRING

Disclosed are prenatal and lactation supplements for pregnant women and lactating women, which include a combination of RRR-alpha-tocopherol, docosahexaenoic acid (DHA), trans-lutein, phospholipids, and at least one nuclear receptor activating ligand other than RRR-alpha-tocopherol, DHA, and trans-l...

Full description

Saved in:
Bibliographic Details
Main Authors LAI, CHRON-SI, KUCHAN, MATTHEW, GONZALEZ, MARIA RAMIREZ, SANTOS, ANGELA, DELGADO, ELENA, OLIVEROS, SHERRY, CHRISTINA LYNN, KATZ, GARY, BLOCH, TAMA
Format Patent
LanguageEnglish
French
German
Published 17.02.2016
Subjects
FOODS OR FOODSTUFFS
FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT
THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online AccessGet full text

Cover

More Information
Summary:Disclosed are prenatal and lactation supplements for pregnant women and lactating women, which include a combination of RRR-alpha-tocopherol, docosahexaenoic acid (DHA), trans-lutein, phospholipids, and at least one nuclear receptor activating ligand other than RRR-alpha-tocopherol, DHA, and trans-lutein. The supplements may enhance central nervous system development in a fetus or breast-feeding newborn infant.
Bibliography:Application Number: EP20140718846